Cargando…
Glaucocalyxin A Inhibits Platelet Activation and Thrombus Formation Preferentially via GPVI Signaling Pathway
Platelets play a pivotal role in atherothrombosis and the antiplatelet agents have been proved to be useful in preventing onset of acute clinical events including myocardial infarction and stroke. Increasing number of natural compounds has been identified to be potential antiplatelet agents. Here we...
Autores principales: | Li, Wei, Tang, Xiaorong, Yi, Wenxiu, Li, Qiang, Ren, Lijie, Liu, Xiaohui, Chu, Chunjun, Ozaki, Yukio, Zhang, Jian, Zhu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875551/ https://www.ncbi.nlm.nih.gov/pubmed/24386454 http://dx.doi.org/10.1371/journal.pone.0085120 |
Ejemplares similares
-
Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation
por: Nestele, Jeremy A., et al.
Publicado: (2021) -
The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation()
por: Walsh, T.G., et al.
Publicado: (2014) -
The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Hoermann, Henrike, et al.
Publicado: (2021) -
Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
por: Jooss, Natalie J., et al.
Publicado: (2022) -
A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI
por: Shih, Tzenge‐Lien, et al.
Publicado: (2021)